Crossmark

Comparative evaluation of isavuconazonium sulfate, voriconazole, and posaconazole for the management of invasive fungal infections in an academic medical center

Crossref DOI link: https://doi.org/10.1186/s12941-019-0311-3

Published Online: 2019-03-20

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Van Matre, Edward T. https://orcid.org/0000-0001-9125-9509
Evans, Shelby L.

Mueller, Scott W.

MacLaren, Robert

Fish, Douglas N.

Kiser, Tyree H. https://orcid.org/0000-0001-7415-3999
Funding

Funding for this research was provided by:

Astellas Pharma US (ISR001425)
License Information

Text and Data Mining valid from 2019-03-20
More Information

Article History

Received: 23 December 2018

Accepted: 1 March 2019

First Online: 20 March 2019

Document is current

Any future updates will be listed below